These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 4649767)

  • 1. [Prevention of galactosamine hepatitis using administration of D-galactose: significance of temporally limited UDP-galactose deficit for the induction of galactosamine hepatitis].
    Bauer C; Reutter W; Bachmann W; Lesch R
    Hoppe Seylers Z Physiol Chem; 1972 Oct; 353(10):1502. PubMed ID: 4649767
    [No Abstract]   [Full Text] [Related]  

  • 2. Preventive effects of 5-fluorouridine and uridine on d-galactosamine-induced liver injury.
    Holstege A; Anukarahanonta T; Yamamoto M; Koch HK; Kattermann R; Lesch R; Keppler D
    Exp Mol Pathol; 1981 Apr; 34(2):170-82. PubMed ID: 6162676
    [No Abstract]   [Full Text] [Related]  

  • 3. 45Calcium uptake during the transition from reversible to irreversible liver injury induced by D-galactosamine in vivo.
    Schiessel C; Forsthove C; Keppler D
    Hepatology; 1984; 4(5):855-61. PubMed ID: 6207090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intravenous and oral galactose loading of rats suffering from galactosamine hepatitis and ANIT-cholestasis; comparison of the kinetics in vivo and the galactose metabolism in the liver in vitro (author's transl)].
    Richter E; Hofstetter GJ; Seifert H
    Z Gastroenterol; 1979 Oct; 17(10):713-21. PubMed ID: 524947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of uridine diphosphoglucose dehydrogenase by galactosamine-I-phosphate and UDP-galactosamine.
    Bauer C; Reutter W
    Biochim Biophys Acta; 1973 Jan; 293(1):11-4. PubMed ID: 4734370
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevention of the hepatotoxic effects of D-galactosamine by D-galactose.
    Mészáros K; Antoni F; Hrabák A; Szikla C; Garzó T; Tompa A; Lapis K
    FEBS Lett; 1973 Sep; 35(1):1-3. PubMed ID: 4751995
    [No Abstract]   [Full Text] [Related]  

  • 7. [The effect of ubiquinone-10 on the development of D-galactosamine-induced hepatitis in rats].
    Sugrobova NP; Medvednik RS; Efimova LV; Katarzhnova TV; Liubarev AE; Shaposhnikov VM; Obol'nikova EA; Poznanskaia AA
    Biull Eksp Biol Med; 1992 Nov; 114(11):504-6. PubMed ID: 1290824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of D-penicillamine on the galactosamine hepatitis model in the rat].
    Habersang S; Kozlik V; Leuschner F; von Schlichtegroll A
    Arzneimittelforschung; 1973 Jan; 23(1):56-7. PubMed ID: 4740696
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of Cuban red propolis on galactosamine-induced hepatitis in rats.
    Rodríguez S; Ancheta O; Ramos ME; Remírez D; Rojas E; González R
    Pharmacol Res; 1997 Jan; 35(1):1-4. PubMed ID: 9149308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatoprotective effect of silymarin (carsil) on liver of D-galactosamine treated rats. Biochemical and morphological investigations.
    Tyutyulkova N; Tuneva S; Gorantcheva U; Tanev G; Zhivkov V; Chelibonova-Lorer H; Bozhkov S
    Methods Find Exp Clin Pharmacol; 1981; 3(2):71-7. PubMed ID: 7230979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The anti-hepatotoxic effect of parenterally administered silymarin in galactosamine hepatitis of the rat].
    Schriewer H; Rausen HM
    Arzneimittelforschung; 1973 Jan; 23():Suppl:159. PubMed ID: 4740687
    [No Abstract]   [Full Text] [Related]  

  • 12. Protective effects of Alpha-tocopherol on the hepatotoxicity of D-galactosamine.
    Mihas AA; Doos W; Gibson RG; Hirschowitz BI
    Ala J Med Sci; 1976 Oct; 13(4):384-7. PubMed ID: 984338
    [No Abstract]   [Full Text] [Related]  

  • 13. Galactosamine hepatitis: key role of the nucleotide deficiency period in the pathogenesis of cell injury and cell death.
    Decker K; Keppler D
    Rev Physiol Biochem Pharmacol; 1974; (71):77-106. PubMed ID: 4375846
    [No Abstract]   [Full Text] [Related]  

  • 14. The regulation of pyrimidine nucleotide level and its role in experimental hepatitis.
    Decker K; Keppler D; Pausch J
    Adv Enzyme Regul; 1973; 11():205-30. PubMed ID: 4132880
    [No Abstract]   [Full Text] [Related]  

  • 15. Investigations on d-galactosamine hepatitis after pretreatment with alpha-hexachlorocyclohexane.
    Schuchhardt C; Reutter W; Lesch R
    Beitr Pathol; 1976 Feb; 157(1):45-55. PubMed ID: 57771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mechanism of action of D-galactosamine in the liver].
    Keppler D; Decker K
    Verh Dtsch Ges Inn Med; 1971; 77():1182-5. PubMed ID: 5155985
    [No Abstract]   [Full Text] [Related]  

  • 17. [Protective and curative effects of diethyldithiocarbamate on galactosamine hepatitis in the rat (author's transl)].
    Homann J; Gerhardt H; Hopf F
    Arzneimittelforschung; 1980; 30(4):645-7. PubMed ID: 6249330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of uridine entrapped in liposomes in galactosamine-induced hepatitis.
    Mathias C; Dorai DT; Bachhawat BK
    Indian J Biochem Biophys; 1977 Jun; 14(2):142-6. PubMed ID: 590978
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of silymarin (Carsil) on the microsomal glycoprotein and protein biosynthesis in liver of rats with experimental galactosamine hepatitis.
    Tyutyulkova N; Gorantcheva U; Tuneva S; Chelibonova-Lorer H; Gavasova E; Zhivkov V
    Methods Find Exp Clin Pharmacol; 1983; 5(3):181-4. PubMed ID: 6888084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Galactosamine hepatitis: injury to the plasma membrane of hepatic cells following administration of D-galactosamine].
    Reutter W; Bachmann W
    Verh Dtsch Ges Inn Med; 1971; 77():1177-8. PubMed ID: 5155984
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.